Before the open on August 6, Aurora Cannabis (ACB) updated the market with a positive pre-announcement on FQ4 results for the period ending in June. Apparently, the company remains on track to positive adjusted EBITDA targets by reaching revenue growth not supported by Health Canada sales data. Investors are urged to remain cautious on the stock with mounting cannabis inventories in the Canadian market over shadowing short-term results.
Image Source: Aurora Cannabis website
Conflicting Market Data
Prior to this preliminary financial update from Aurora Cannabis, my model was predicting a difficult time for